Results 101 to 110 of about 9,652,955 (180)

"Treated like a Human Being": perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City. [PDF]

Harm Reduct J, 2023
Kapadia SN, Aponte-Melendez Y, Rodriguez A, Pai M, Eckhardt BJ, Marks KM, Fong C, Mateu-Gelabert P.   +7 more
europepmc   +1 more source

Harm reduction among injecting drug users - evidence of effectiveness [PDF]

, 2010
This chapter synthesises and evaluates the available direct evidence relating to the impact of needle and syringe programmes (NSPs), opioid substitution treatment (OST), drug consumption rooms (DCRs), and peer naloxone distribution (PND) on HIV/hepatitis
Hutchinson, Sharon, Kimber, Jo, Palmateer, Norah, Goldberg, David, Rhodes, Tim, Hickman, Matthew   +5 more
core  

Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine. [PDF]

J Addict Med, 2023
Corcorran MA, Austin EJ, Behrends CN, Briggs ES, Frost MC, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN.   +15 more
europepmc   +1 more source

"We were building the plane as we were flying it, and we somehow made it to the other end": syringe service program staff experiences and well-being during the COVID-19 pandemic. [PDF]

Harm Reduct J, 2022
Wang A, Jawa R, Mackin S, Whynott L, Buchholz C, Childs E, Bazzi AR.   +6 more
europepmc   +1 more source

Unmet needs and harm reduction preferences of syringe services program participants: differences by co-use of illicit opioids and methamphetamine

Harm Reduction Journal
Background The current fourth wave of the United States opioid overdose epidemic is characterized by the co-use of opioids and stimulants, including illicit opioids and methamphetamine. The co-use of these two drugs, known as “goofballing,” is associated
Rachel Sun, Tonazzina H. Sauda, Rachel A. Hoopsick   +2 more
doaj   +1 more source

Steroid users and the unique challenge they pose to needle and syringe program workers

, 2014
Steroid users and the unique challenge they pose to needle and syringe program ...
J Iversen (9856193), Fiona McKay (13069920), Matthew Dunn (13067364)   +2 more
core  

Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol

BMC Infectious Diseases
Background As many as 2.4 million Americans are affected by chronic Hepatitis C Virus (HCV) in the United States.In 2018, the estimated number of adults with a history of HCV infection in San Diego County was 55,354 (95% CI: 25,411–93,329).
Stacey L. Klaman, Job G. Godino, Adam Northrup, Sydney V. Lewis, Aaron Tam, Carolina Carrillo, Robert Lewis, Eva Matthews, Blanca Mendez, Letty Reyes, Sarah Rojas, Christian Ramers   +11 more
doaj   +1 more source

Do steroid users pose unique challenges for needle and syringe program staff?

, 2013
Do steroid users pose unique challenges for needle and syringe program ...
J Iversen (9856193), Fiona McKay (13069920), Matthew Dunn (13067364)   +2 more
core  

Reducing harms from injection drug use & opioid use disorder with syringe services programs [PDF]

This info sheet shows information about Reducing Harms from Injection Drug Use & Opioid Dependency with Syringe Service Programs.cdchiv-fs-syringe-services ...

core  

Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients. [PDF]

Int J Drug Policy, 2022
Sivakumar A, Madden L, DiDomizio E, Eller A, Villanueva M, Altice FL.   +5 more
europepmc   +1 more source